pre-IPO PHARMA

COMPANY OVERVIEW

At Sen-Jam Pharmaceutical we disrupt pain and inflammation. Sen-Jam Pharmaceutical's mission is to improve societal wellbeing by developing therapeutics that are safe, efficacious, and accessible by all. Sen-Jam repurposes small molecules to develop novel therapeutics for large unmet needs with a focus on improving clinical outcomes for patients battling opioid use disorder, viral respiratory infections from coronaviruses such as COVID-19 and other painful inflammation and toxin-induced conditions, including arthritis, vaccinations, and even the infamous hangover. Using patented proprietary technology and the accelerated 505(b)2 pathway, Sen-Jam is on a mission to revolutionize pain treatment and the business of pain relief.


LOCATION

  • Huntington, NY, USA

  • THERAPEUTIC AREAS

  • Autoimmune Disease
  • Pain

  • WEBSITE

    https://sen-jam.com/


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    May 3, 2023

    Sen-Jam Pharmaceutical Continues Partnership With Specialty Pharmaceutical Manufacturer to Provide Formulation and Chemistry, Manufacturing and Controls for Innovative Alcohol Hangover Prevention Therapeutic


    Oct 14, 2022

    Sen-Jam Pharmaceutical, the World's Most Resourceful Drug Innovator, Turns to Both Private and Institutional Investors to Secure Series A Financing to Further Advance Critical Therapeutics


    Sep 22, 2022

    People Science™ and Sen-Jam Pharmaceutical partner to develop people-forward tools to study inflammation, pain, and opioid withdrawal symptoms in the real world


    Jul 29, 2022

    Sen-Jam Pharmaceutical, The World's Most Resourceful Drug Innovator, Turns To Crowdfunding To Secure Financing To Advance Critical Therapeutics


    Jun 20, 2022

    Sen-Jam Pharmaceutical Names Award-winning Scientist and Thought Leader Dr. Alexander Wissner-Gross to Advisory Board


    For More Press Releases


    Google Analytics Alternative